Is it time to introduce repetitive transcranial magnetic stimulation into standard clinical practice for the treatment of depressive disorders?
Fitzgerald P.
Aust N Z J Psychiatry. 2003 Feb;37(1):5-11; discussion 12-4

OBJECTIVE: To examine issues relating to the potential introduction of
repetitive transcranial magnetic stimulation (rTMS) into clinical practice as a
treatment for depression. METHOD: A review of the outcomes literature
accompanied by an analysis of issues relating to the potential advantages and
pitfalls of the introduction of rTMS as a treatment strategy. RESULTS: Evidence
is progressively accumulating that rTMS has antidepressant properties that are
clinically relevant. These effects are biologically plausible and supported by
basic research. Patients with therapy-resistant depression have few treatment
alternatives and experience significant suffering, thus justifying the early
introduction of a new treatment such as rTMS for this patient group. However,
this must be balanced by a need to foster considerable further research and not
to raise expectations unreasonably. CONCLUSIONS: It is timely for rTMS to be
made more available to patients with treatment-resistant mood disorders. This
need not be limited to clinical research trials but should only occur in medical
settings where continual evaluation and research is conducted.

Voltar

 

Eletromagnetismo

Bioeletricidade
em Psiquiatría